Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
7-12-2019

Effects of microbiota-directed foods in gnotobiotic animals and
undernourished children
Jeanette L Gehrig
Washington University School of Medicine in St. Louis

Siddarth Venkatesh
Washington University School of Medicine in St. Louis

Hao-Wei Chang
Washington University School of Medicine in St. Louis

Matthew C Hibberd
Washington University School of Medicine in St. Louis

Vanderlene L Kung
Washington University School of Medicine in St. Louis

See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Gehrig, Jeanette L; Venkatesh, Siddarth; Chang, Hao-Wei; Hibberd, Matthew C; Kung, Vanderlene L; Cheng,
Jiye; Chen, Robert Y; Subramanian, Sathish; Cowardin, Carrie A; Meier, Martin F; O'Donnell, David; Talcott,
Michael; Spears, Larry D; Semenkovich, Clay F; Sawyer, Christopher; Head, Richard D; Barratt, Michael J;
Gordon, Jeffrey I; and et al, ,"Effects of microbiota-directed foods in gnotobiotic animals and
undernourished children." Science. 365,6449. . (2019).
https://digitalcommons.wustl.edu/open_access_pubs/9540

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Jeanette L Gehrig, Siddarth Venkatesh, Hao-Wei Chang, Matthew C Hibberd, Vanderlene L Kung, Jiye
Cheng, Robert Y Chen, Sathish Subramanian, Carrie A Cowardin, Martin F Meier, David O'Donnell, Michael
Talcott, Larry D Spears, Clay F Semenkovich, Christopher Sawyer, Richard D Head, Michael J Barratt,
Jeffrey I Gordon, and et al

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/9540

Corrected 11 July 2019. See full text.
R ES E A RC H

RESEARCH ARTICLE SUMMARY

◥

MICROBIOTA

Effects of microbiota-directed
foods in gnotobiotic animals and
undernourished children

INTRODUCTION: There is a dimension to postnatal human development that involves assembly of microbial communities in different body
habitats, including the gut. Children with acute
malnutrition have impaired development of their
gut microbiota, leaving them with communities
that appear younger (more immature) than those
of chronologically age-matched healthy individuals. Current therapeutic foods given to children
with acute malnutrition have not been formulated based on knowledge of how they affect the
developmental biology of the gut microbiota.
Moreover, they are largely ineffective in ameliorating the long-term sequelae of malnutrition
that include persistent stunting, neurodevelopmental abnormalities, and immune dysfunction.
RATIONALE: Repairing microbiota immatu-

rity and determining the degree to which such

repair restores healthy growth requires identification of microbial targets that are not only
biomarkers of community assembly but also
mediators of various aspects of growth. Identifying ingredients in complementary foods,
consumed during the transition from exclusive
milk feeding to a fully weaned state, that increase the representation and expressed beneficial functions of growth-promoting bacterial
taxa in the developing microbiota could provide an effective, affordable, culturally acceptable, and sustainable approach to treatment.
RESULTS: Metabolomic and proteomic analyses of serially collected plasma samples were
combined with metagenomic analyses of serially collected fecal samples from Bangladeshi
children with severe acute malnutrition (SAM)
treated with standard therapy. The results

◥

CONCLUSION: These findings demonstrate
the translatability of results obtained from preclinical gnotobiotic animal models to humans,
directly support the hypothesis that healthy
microbiota development is causally linked to
healthy growth, illustrate an approach for treating childhood undernutrition, and with the
capacity to deliberately reconfigure immature
microbiota, suggest a means to decipher how
elements of the gut microbial community operate to regulate various host systems involved
in healthy growth.

▪

Overview of therapeutic food discovery and testing. The approach used for integrating
preclinical gnotobiotic animal models with human studies to understand the contributions of
perturbed gut microbiota development to childhood malnutrition and to identify MDCFs.
Gehrig et al., Science 365, 139 (2019)
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provided a readout of their biological features
as they transitioned from SAM to a state of
persistent moderate acute malnutrition (MAM)
with accompanying persistent microbiota
immaturity. Significant correlations were identified between levels of plasma proteins, anthropometry, plasma metabolites, and the
representation of bacteria in their microbiota.
Gnotobiotic mice were subsequently colonized
with a defined consortium of bacterial strains
that represent various phases of microbiota
development in healthy Bangladeshi children.
Administration of different combinations of
Bangladeshi complementary food ingredients
to colonized mice and germ-free controls revealed diet-dependent increases in the abundance and changes in the metabolic activities
of targeted weaning-phase
ON OUR WEBSITE
strains as well as diet- and
colonization-dependent
Read the full article
augmentation of growthat http://dx.doi.
org/10.1126/
promoting host signaling
science.aau4732
pathways. Host and micro..................................................
bial effects of microbiotadirected complementary food (MDCF) prototypes
were subsequently examined in gnotobiotic
mice colonized with immature microbiota from
children with post-SAM MAM and in gnotobiotic piglets colonized with a defined consortium of targeted age- and growth-discriminatory
taxa. A randomized, double-blind study of standard therapy versus various MDCF prototypes
emerging from these preclinical models, conducted in Bangladeshi children with MAM,
identified a lead MDCF that increased levels of
biomarkers and mediators of growth, bone formation, neurodevelopment, and immune function toward a state resembling healthy children.
Using an approach inspired by statistical methods applied to financial markets, we show in the
accompanying paper by Raman et al. that this
lead MDCF was most effective in repairing the
microbiota.
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MICROBIOTA

Effects of microbiota-directed
foods in gnotobiotic animals and
undernourished children

To examine the contributions of impaired gut microbial community development to
childhood undernutrition, we combined metabolomic and proteomic analyses of plasma
samples with metagenomic analyses of fecal samples to characterize the biological state
of Bangladeshi children with severe acute malnutrition (SAM) as they transitioned, after
standard treatment, to moderate acute malnutrition (MAM) with persistent microbiota
immaturity. Host and microbial effects of microbiota-directed complementary food
(MDCF) prototypes targeting weaning-phase bacterial taxa underrepresented in SAM and
MAM microbiota were characterized in gnotobiotic mice and gnotobiotic piglets colonized
with age- and growth-discriminatory bacteria. A randomized, double-blind controlled
feeding study identified a lead MDCF that changes the abundances of targeted bacteria
and increases plasma biomarkers and mediators of growth, bone formation,
neurodevelopment, and immune function in children with MAM.

E

vidence is accumulating that disruption
of “normal” gut community (microbiota)
development may contribute to the pathogenesis of undernutrition. Using cultureindependent surveys, bacterial membership
has been defined in fecal samples collected monthly during the first 2 postnatal years from healthy
members of a birth cohort living in an urban
slum (Mirpur) in Dhaka, Bangladesh (1, 2). Applying machine learning [Random Forests (RF)]
to the resulting 16S ribosomal DNA (rDNA) dataset yielded a “sparse” model composed of the most
age-discriminatory bacterial strains; changes in
the relative abundances of these organisms described a program of normal microbiota development (2). This RF-derived model was subsequently
used to characterize fecal samples collected from

Bangladeshi children with severe acute malnutrition [SAM; defined as a weight-for-height
z-score (WHZ) >3 standard deviations below the
median for a World Health Organization (WHO)
reference healthy growth cohort (3)]. The results
revealed gut communities that resembled those
of healthy children who were chronologically
younger. This microbiota “immaturity” was more
pronounced in children with SAM as compared
with those with moderate acute malnutrition
(MAM; WHZ score between –2 and –3) and was
not repaired in a clinical study that tested the
effects of two therapeutic foods (2).
Impaired microbiota development has also
been documented in undernourished Malawian
children (4). To examine the functional importance of this impairment, microbial communi-

1
Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA. 2Center for Gut Microbiome and Nutrition Research,
Washington University School of Medicine, St. Louis, MO 63110, USA. 3Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. 4Division
of Comparative Medicine, Washington University, St. Louis, MO 63110, USA. 5Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. 6Architecture et
Fonction des Macromolécules Biologiques, Centre National de la Recherche Scientifique and Aix-Marseille Université, 13288 Marseille cedex 9, France. 7Department of Biological Sciences, King
Abdulaziz University, Jeddah, Saudi Arabia. 8Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA. 9Sarah W. Stedman Nutrition and Metabolism Center, Duke
University Medical Center, Durham, NC 27710, USA. 10Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC 27710, USA. 11Department of Pharmacology and Cancer
Biology, Duke University Medical Center, Durham, NC 27710, USA. 12Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. 13Department of Genetics, Washington
University School of Medicine, St. Louis, MO 63110, USA. 14Genome Technology Access Center, Washington University School of Medicine, St. Louis, MO 63110, USA. 15A. A. Kharkevich Institute
for Information Transmission Problems, Russian Academy of Sciences, Moscow 127994, Russia. 16Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery
Institute, La Jolla, CA 92037, USA. 17International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh.

*These authors contributed equally to this work. †Present address: Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
‡Corresponding author. Email: jgordon@wustl.edu

Gehrig et al., Science 365, eaau4732 (2019)

12 July 2019

1 of 12

Downloaded from http://science.sciencemag.org/ on September 30, 2020

Jeanette L. Gehrig1,2*, Siddarth Venkatesh1,2*, Hao-Wei Chang1,2*,
Matthew C. Hibberd1,2, Vanderlene L. Kung1,2,3, Jiye Cheng1,2, Robert Y. Chen1,2,
Sathish Subramanian1,2†, Carrie A. Cowardin1,2, Martin F. Meier1,2, David O’Donnell1,2,
Michael Talcott4, Larry D. Spears5, Clay F. Semenkovich5, Bernard Henrissat6,7,
Richard J. Giannone8, Robert L. Hettich8, Olga Ilkayeva9,10, Michael Muehlbauer9,10,
Christopher B. Newgard9,10,11,12, Christopher Sawyer13,14, Richard D. Head13,14,
Dmitry A. Rodionov15,16, Aleksandr A. Arzamasov15,16, Semen A. Leyn15,16,
Andrei L. Osterman16, Md Iqbal Hossain17, Munirul Islam17, Nuzhat Choudhury17,
Shafiqul Alam Sarker17, Sayeeda Huq17, Imteaz Mahmud17, Ishita Mostafa17,
Mustafa Mahfuz17, Michael J. Barratt1,2, Tahmeed Ahmed17, Jeffrey I. Gordon1,2‡

ties from healthy and stunted or underweight
6- and 18-month-old Malawian children were
transplanted into groups of recently weaned
germ-free mice fed a diet representative of that
consumed by the human donor population. The
results disclosed that compared with mice colonized with normally maturing microbiota from
the healthy donors, animals harboring immature microbiota exhibited reduced rates of lean
body mass gain, alterations in bone growth, and
metabolic abnormalities (4). These studies provided preclinical evidence for a causal link between microbiota immaturity and undernutrition;
they also revealed that a subset of the agediscriminatory strains is growth-discriminatory.
Moreover, a cultured consortium of these ageand growth-discriminatory taxa ameliorated
the impaired growth phenotype transmitted to
recipient gnotobiotic mice by an immature microbiota (4).
One question arising from these observations
is, how do we design optimal foods that steer a
microbiota into an age-appropriate and healthy
state? Breastfeeding plays a major role in reducing childhood malnutrition. As such, WHO and
the United Nations Children’s Fund (UNICEF)
recommend exclusive breastfeeding for the first
6 months of postnatal life and continued breastfeeding after the introduction of complementary
foods up to 24 months of age (5). Suboptimal
complementary feeding practices are important
contributors to malnutrition in children less than
2 years of age (6). However, current complementary feeding recommendations are not based on
knowledge of how foods affect the developmental biology of the gut microbiota during the
weaning process. Together, these observations
raise the question: Do certain complementary
food ingredients or combinations of ingredients
have the ability to selectively increase the representation and expressed beneficial functions of
age- and growth-discriminatory strains deficient
in SAM- or MAM-associated microbiota? If the
answer is yes, then prescribed feeding of these
ingredients could help “repair” or prevent development of microbiota immaturity in children, with potentially long-lived, health-promoting
effects.
Here, we describe a process for identifying
microbiota-directed complementary foods (MDCFs)
designed to treat children with acute malnutrition. We first characterized gut microbial community and host responses over the course of
12 months in Bangladeshi children who were
treated for SAM with one of three conventional
therapeutic foods. Measurement of the levels of
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charge, and 6 months after discharge for targeted mass spectrometry (MS)–based metabolic
profiling; a sufficient quantity of blood was obtained from eight children at all three time points
for aptamer-based proteomics analysis (8–10).
Of these children, 44% had MAM at 12 months
of followup. None of the therapeutic foods produced a significant effect on their severe stunting [height-for-age z-score (HAZ)] (Fig. 1B and
table S1B).
Metabolic phenotypes
Targeted MS of plasma samples obtained at enrollment revealed high levels of ketones, nonesterified fatty acids (NEFA), and medium to long
even-chain acylcarnitines (Fig. 2, A and B, and
table S2), which is consistent with the known
acute malnutrition-induced lipolytic response
that raises circulating fatty acids and activates
fatty acid oxidation (11). By discharge, this metabolic feature had normalized, whereas levels of a
number of amino acids had increased significantly, including the gluconeogenic amino acid
alanine; the branched-chain amino acids leucine,
isoleucine, and valine; plus products of branchedchain amino acid metabolism [C3 (propionyl)carnitine and their ketoacids] (Fig. 2, A to C).
These findings suggest that the increased protein
provided by the therapeutic foods prompted a
switch from fatty acid to amino acid oxidation,
leading to repletion of fat depots, increases in

plasma leptin (Fig. 2A), and weight gain (table
S1B). However, 6 months after treatment, multiple plasma amino acids and their metabolites
had declined to levels comparable with those at
admission, whereas fatty acids and fatty acid–
derived metabolites remained at similar concentrations to those observed at discharge (Fig. 2, A
to C). Insulin-like growth factor 1 (IGF-1) levels
did not change significantly during this period
(Fig. 2A), potentially explaining the absence of a
signature of pronounced lipolysis that had been
observed at enrollment. Although the suppression
of lipolysis at 6 months after discharge suggests a
sustained effect of nutritional resuscitation, the
fall in essential amino acids and the lower level
of IGF-1 compared with that found in similarly
aged healthy children from the same community
(44.5 versus 69.4 ng/mL; P = 0.02, t test) may
contribute to the observed failure to achieve catchup growth.
The plasma proteome
Significant correlations between levels of plasma
proteins, anthropometric indices, plasma metabolites, and host signaling pathways regulating
key facets of growth are described in the supplementary text, results (table S3, A and B)—for
example, components of the growth hormone
(GH)–IGF axis, including soluble growth hormone receptor (also known as growth hormone
binding protein), multiple IGF binding proteins

Effects of conventional therapeutic
foods on the biological state
of children with SAM
A total of 343 Bangladeshi children aged 6 to
36 months with SAM were enrolled in a multicenter, randomized, double-blind “noninferiority”
study designed to compare two locally produced
therapeutic foods (supplementary materials, materials and methods) with a commercially available,
ready-to-use therapeutic food (RUTF) (7) (study
design is provided in Fig. 1A, and the compositions of these therapeutic foods are available in
table S1A). Children received standard management for SAM during the acute stabilization phase
of in-hospital treatment, including a short course
of antibiotics. Eligible children were then randomized to one of the three therapeutic food
arms (~200 kcal/kg/day, mean duration 16.1 ±
10.3 days) (table S1B). Children were discharged
after meeting criteria described in the supplementary materials, materials and methods. In a
subset of 54 children, fecal samples were collected
at enrollment [age 15.2 ± 5.1 months (mean ± SD)]
before randomization, twice during treatment
with a therapeutic food, and at regular intervals
up to 12 months after discharge (Fig. 1A; clinical
metadata is available in table S1B). Blood samples
(plasma) were also obtained at enrollment, disGehrig et al., Science 365, eaau4732 (2019)

Fig. 1. Longitudinal study of Bangladeshi children with SAM treated with therapeutic foods.
(A) Study design. (B) Anthropometry and MAZ scores. Gray bars represent the three time points
at which blood samples were collected. (C) Summary of MAZ scores for children with SAM
(WHZ < –3; n = 96 fecal samples) and subsequently (post-SAM) MAM (WHZ > –3 and <–2; n =
151 fecal samples), plus healthy children aged 6 to 24 months living in the same area in which the
SAM study was conducted (n = 450 fecal samples). Mean values for WHZ, WAZ, HAZ, and
MAZ ± SEM are plotted on the x axes of (B) and (C). ****P < 0.0001 (one-way ANOVA followed
by Tukey’s multiple comparisons test).
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1305 human plasma proteins—including regulators and effectors of physiologic, metabolic, and
immune functions—combined with mass spectrometric profiling of plasma metabolites and
culture-independent analyses of serially collected fecal samples provided a “readout” of the
biological features of these children as they progressed from SAM to a state of incomplete recovery (post-SAM MAM) with persistent microbiota
immaturity. This readout included correlations
between plasma proteins, anthropometry, plasma metabolites, and the representation of agediscriminatory members of their microbiota. We
then screened complementary foods in gnotobiotic mice colonized with a consortium of bacterial strains that had been cultured from children
living in Mirpur to identify ingredients that
promote the representation of constituent agediscriminatory strains that are underrepresented
in the setting of acute malnutrition. Subsequently,
a representative microbiota from a child with
post-SAM MAM was transplanted into gnotobiotic mice. Recipient animals were fed a diet
resembling that consumed by children in Mirpur
but supplemented with ingredients identified in
the screen, in order to establish whether one or
more of these MDCF formulations could repair
a microbiota from a subject who had already
received conventional therapy. Lead formulations were subsequently tested in gnotobiotic
piglets colonized with a defined consortium of
age- and growth-discriminatory strains to test
their biological effects in a host species that is
physiologically and metabolically more similar
to humans than mice. Last, three MDCF prototypes were administered to children with MAM,
and their effects on the microbiota and host biological state were determined.
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(IGFBPs), and regulators of IGFBP turnover (the
metalloprotease pappalysin-1 and its inhibitor
stanniocalcin-1).
The gut microbiome
A sparse RF-derived model of normal gut microbiota development comprising 30 bacterial taxa
[operational taxonomic units (OTUs)] and obtained from 25 healthy members of a birth cohort
living in Mirpur (table S4, A to C) was applied
to bacterial V4-16S rDNA datasets generated
from fecal samples serially collected from the
children in the SAM study (n = 539 samples). This
model allowed us to define microbiota-for-age
z-scores (MAZ) as a function of treatment arm
and time [9.3 ± 3.7 samples/child (mean ± SD)].
The MAZ score measures the deviation in development of a child’s microbiota from that of
chronologically age-matched reference healthy
children on the basis of the representation of
the ensemble of age-discriminatory strains contained in the RF-derived model (2). Significant
microbiota immaturity was apparent in the SAM
and post-SAM MAM groups (Fig. 1C and table
S5A). Moreover, MAZ-scores in this SAM cohort
were significantly correlated with WHZ, HAZ,
Gehrig et al., Science 365, eaau4732 (2019)

and WAZ [Pearson correlation coefficient (r) =
0.16, P = 0.0004; r = 0.13, P = 0.003; and r = 0.10,
P = 0.02, respectively]. The MAZ score was not
different at discharge but improved 1 month later
(P = 0.0051 versus admission, Mann-Whitney
test). This improvement could reflect increased
dietary diversity, reduced antibiotic usage (table
S1B), and/or other factors associated with returning to the home environment. MAZ-scores did
not change significantly thereafter (Fig. 1B).
A number of the age-discriminatory strains
were significantly correlated with anthropometric indices as well as with plasma proteins
involved in biological processes that mediate
growth. We also identified significant negative
correlations between these taxa and mediators
of systemic inflammation and anorexia/cachexia.
Bifidobacterium longum (OTU 559527) had the
greatest number of significant correlations (114)
[table S3C; further discussion is available in supplementary text, results].
The effects of the therapeutic food interventions on the representation of metabolic pathways in the gut microbiome were defined by
shotgun sequencing of 331 fecal DNA samples
obtained from 30 members of the Mirpur birth

12 July 2019

cohort with consistently healthy anthropometry and 15 of the 54 children enrolled in the
SAM study (table S5B); these 15 children were
selected according to their age (12 to 18 months)
and that we had corresponding plasma metabolomic and proteomic datasets for at least two of
the three time points sampled. The abundances
of microbial genes that mapped to pathways in
the microbial communities SEED (mcSEED) database (12)—related to metabolism of amino acids,
carbohydrates, fermentation products, and B
vitamins and related cofactors—were first defined in healthy children sampled monthly from
birth to 2 years of age. A set of age-discriminatory
metabolic pathways (mcSEED “subsystems” or
pathway modules) was identified. The resulting
sparse RF-derived model (fig. S1, A and B, and
materials and methods) allowed us to assign a
state of development (functional age or “maturity”) to the fecal microbiomes of the 15 children
treated for SAM. Relative functional maturity was
significantly correlated with MAZ, WHZ, and WAZ
scores during the course of the trial (Pearson r
and P values are MAZ, r = 0.55, P < 0.0001; WHZ,
r = 0.30, P = 0.0011; WAZ, r = 0.23, P = 0.013).
At enrollment, and just before administration of
3 of 12
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Fig. 2. Metabolic features of children with SAM before and after treatment. (A to C) Levels of (A) standard clinical metabolites and selected
hormones, (B) acylcarnitines, and (C) amino acids and ketoacids in plasma collected from children at enrollment (Fig. 1A, B1 blood sample),
discharge (Fig. 1A, B2 sample), and 6 months after discharge (Fig. 1A, B3 sample). Abbreviations for branched chain ketoacids in (C) are KIC,
a-ketoisocaproate; KIV, a-ketoisovalerate; and KMV, a-keto-b-methylvalerate. Mean values ± SEM are plotted. *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001 (paired t test followed by FDR correction).

Corrected 11 July 2019. See full text.
R ES E A RC H | R E S EA R C H A R T I C LE

Screening complementary
food ingredients
Nine age-discriminatory bacterial strains were
cultured from the fecal microbiota of three
healthy children, aged 6 to 23 months, who lived
in Mirpur, and genomes of these isolates were
sequenced (table S6, A and C). Seven of the
nine isolates had V4-16S rDNA sequences that
corresponded to age-discriminatory OTUs whose
representation is associated with the period of complementary food consumption (“weaning-phase”
OTUs) (fig. S2A), whereas two, Bifidobacterium
longum subsp. infantis and Bifidobacterium
breve, are most prominent during the period of
exclusive, predominant milk feeding (fig. S2A)
(13). OTUs representing seven of the nine cultured strains were significantly depleted in the
fecal microbiota of Bangladeshi children with
SAM before treatment (table S7 and fig. S3). Seven
additional age-discriminatory strains were cultured from the immature fecal microbiota of a
24-month-old child with SAM enrolled in the same
study as the subcohort shown in Fig. 1 (table S6,
A and C). Together, the consortium of 16 strains
represented OTUs that directly matched 65.6 ±
22.8% (mean ± SD) of V4-16S rDNA sequencing
reads generated from 1039 fecal samples collected from 53 healthy members of the Mirpur
birth cohort during their first 2 postnatal years,
and 74.2 ± 25.2% of the reads produced from
fecal samples obtained from 38 children with
SAM (table S7).
To identify complementary foods that selectively increase the representation of weaningphase age-discriminatory strains deficient in
Gehrig et al., Science 365, eaau4732 (2019)

immature SAM-associated microbiota, we colonized 5-week-old, germ-free C57Bl/6J mice
with the consortium of cultured, sequenced bacterial strains. After colonization, an 8-week period of diet “oscillations” was initiated (fig. S2B).
We incorporated 12 complementary food ingredients commonly consumed in Mirpur (6) into
14 different diets using a random sampling strategy (table S8, A to E, and materials and methods). The composition of these complementary
food combinations (CFCs) and their order of administration to mice were based on considerations
described in the legend to fig. S2, B and C.
Spearman’s rank correlation coefficients were
calculated between the relative abundances of
the 14 bacterial strains that colonized mice and
levels of complementary food ingredients in the
14 CFCs tested (fig. S2D and table S9A). Chickpea
and banana had strong positive correlations
with the greatest number of strains representing
weaning-phase age-discriminatory OTUs. Tilapia
had a narrower range of significant positive effects (fig. S2D). Chickpea, banana, and tilapia
also had significant negative correlations with
levels of the preweaning, milk-adapted B. longum
subsp. infantis isolate. A sobering observation was
that a number of complementary food ingredients typically represented in diets consumed
by 18-month-old children living in Mirpur had
significant negative correlations with six of the
weaning-phase age-discriminatory strains, including rice, milk powder, potato, spinach, and
sweet pumpkin (fig. S2D). Rice gruel with milk is
the most common first complementary food
given to Bangladeshi children (14). Moreover,
egg, which is included in a number of regimens
for nutritional rehabilitation of children with acute
malnutrition (15), was negatively correlated with
the abundance of two weaning-phase strains,
Dorea formicigenerans and Blautia luti.
Testing an initial MDCF prototype
Khichuri-halwa (KH) is a therapeutic food commonly administered together with milk-suji (MS)
to Mirpur children with SAM. A previous study
documented the inability of this intervention
to repair gut microbiota immaturity (2). We prepared a diet that mimicked MS and KH (MS/KH)
(table S8, D and E); 7 of its 16 ingredients are
commonly consumed complementary foods that
had little, if any, effect on the representation of
weaning-phase age-discriminatory strains (rice,
red lentils, potato, pumpkin, spinach, whole-wheat
flour, and powdered milk) (fig. S2D). The effects
of MS/KH on members of the 14-member consortium and the host were compared with those
produced by an initial MDCF prototype that contained chickpeas, banana, and tilapia (table S9B).
Five-week-old germ-free C57Bl/6J mice colonized
with the consortium were monotonously fed either
of the two diets ad libitum for 25 days.
Microbial community responses
Community profiling by means of short read
shotgun sequencing (COPRO-seq) of cecal DNA
revealed that compared with MS/KH, consumption of the MDCF prototype resulted in signifi-
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cantly higher relative abundances of a number
of weaning-phase age-discriminatory taxa, including Faecalibacterium prausnitzii, Dorea
longicatena, and B. luti (P < 0.01; Mann-Whitney
test) (Fig. 3A and table S9B). This prototype did
not promote the fitness of the SAM donorderived strains, with the exception of Escherichia
fergusonii.
We used targeted MS to quantify cecal levels
of carbohydrates, short-chain fatty acids, plus
amino acids and their catabolites (table S10, A
to D). Germ-free animals served as reference
controls to define levels of cecal nutrients that,
by inference, would be available for bacterial
utilization in the different diet contexts. There
were several noteworthy findings: (i) Levels of
butyrate and succinate were significantly higher in
colonized animals consuming MDCF compared
with MS/KH (Fig. 3B and table S10B). (ii) There
were no statistically significant diet-associated differences in levels of any of the amino acids measured in germ-free animals, but when compared
with their colonized MS/KH–fed counterparts,
colonized MDCF-consuming animals had significantly elevated cecal levels of six amino acids
classified as essential in humans (the three
branched-chain amino acids leucine, isoleucine,
and valine plus phenylalanine and tryptophan)
(Fig. 3C and table S10C). And (iii) two tryptophanderived microbial metabolites that play important
roles in suppressing inflammation and are neuroprotective, 3-hydroxyanthranillic acid (3-HAA)
and indole-3-lactic acid (16–21), were significantly elevated in colonized animals fed MDCF
compared with their MS/KH–treated counterparts (table S10D).
Findings from RNA-sequencing (RNA-seq)
analysis of the transcriptional responses of community members to the two diets based on Kyoto
Encyclopedia of Genes and Genomes (KEGG)–
and mcSEED-derived annotations of the 40,735
predicted protein-coding genes present in consortium members are described in tables S9C
and S11, A to C, and supplementary text, results,
and in silico predictions of their ability to produce,
use, and/or share nutrients are provided in table
S6, D and E. For example, community-level analysis revealed specific members manifested MDCFassociated increases in expression of genes involved
in biosynthesis of the essential amino acids, including branched-chain amino acids (Ruminococcus
obeum and Ruminococcus torques), and generation
of aromatic amino acid metabolites (R. obeum,
R. torques, and F. prausnitzii) (table S11C, ii).
Host effects
Serum levels of IGF-1 were significantly higher in
colonized mice that consumed the initial MDCF
prototype compared with those that consumed
MS/KH. This effect was diet- and colonizationdependent, with germ-free animals exhibiting
significantly lower levels of IGF-1 in both diet
contexts (Fig. 3D). Serum insulin levels were also
higher in colonized animals that consumed MDCF
compared with MS/KH [800.7 ± 302.9 ng/mL
(mean ± SD) versus 518.7 ± 135.1 ng/mL, respectively; P = 0.06; unpaired t test].
4 of 12
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therapeutic foods, children with SAM had more
immature microbiomes [one-way analysis of variance (ANOVA) P = 0.0002; Dunnett’s multiple
comparisons test for healthy versus SAM adjusted
P values at the two time points, 0.027 and 0.0001,
respectively]. There was a statistically significant
improvement in functional maturity from initiation of therapeutic food treatment to discharge,
and at 1 and 6 months after discharge (Tukey’s
multiple comparisons test; adjusted P values =
0.039, 0.0028, and 0.025, respectively). However,
this improvement was not sustained at later time
points (fig. S1D). Comparing the relative abundances of the 30 most age-discriminatory pathways at six time points revealed that the SAM
microbiome had significantly reduced representation of (i) amino acid metabolic pathways,
including those involved in isoleucine, leucine,
valine biosynthesis, and uptake; (ii) several carbohydrate utilization pathways (arabinose and
arabinosides, rhamnose and rhamnogalacturonan,
and sialic acid); and (iii) multiple pathways
involved in B-vitamin metabolism, including
“niacin/NADP (nicotinamide adenine dinucleotide phosphate) biosynthesis” (fig. S1E and table
S5C). The observed underrepresentation of agediscriminatory OTUs and metabolic pathways
in the gut communities of children with postSAM MAM provided the rationale for developing
a pipeline to test complementary food ingredients
for their ability to repair this immaturity.
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Fig. 3. Comparison of microbial community and host effects of an initial
MDCF prototype versus MS/KH. Separate groups of germ-free mice or animals colonized with the defined consortium of 14 bacterial strains were fed the
two diets, monotonously, for 25 days, after which time they were euthanized, and
cecal contents were analyzed. (A) The relative abundances of strains in the cecal
microbiota of colonized mice. Mean values ± SD shown. (B and C) Diet- and
colonization-dependent effects on (B) cecal levels of short chain fatty acids and
(C) essential amino acids plus the tryptophan metabolite, indole 3-lactic acid.
Each dot represents a sample from a mouse in the indicated treatment group.
Mean values ± SD are shown. ***P < 0.001; ****P < 0.0001 [2-way ANOVA followed by Tukey’s multiple comparisons test for (A) to (C)]. (D) Diet- and colonizationdependent effects on serum IGF-1 levels. (E) Effects of diet on levels of liver

Gehrig et al., Science 365, eaau4732 (2019)
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proteins involved in IGF-1 signaling and IGF-1 production. Levels of phosphorylated proteins were normalized to the total amount of the corresponding
nonphosphorylated protein or to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). (F) Effect of diet and colonization status on the cortical thickness of
femoral bone. (G) Effects of diet in colonized gnotobiotic mice on branchedchain amino acids in serum and acylcarnitines in muscle and liver. [C5-OH/C3
are isobars that are not resolved through flow injection MS/MS. C5-OH is a
mix of 3-hydroxy-2-methylbutyryl carnitine (derived from the classical
isoleucine catabolic intermediate 3-hydroxy-2-methylbutyryl CoA) and
3-hydroxyisovaleryl carnitine (a noncanonical leucine metabolite)]. For (D)
to (G), mean values ± SD are shown. ns, not significant. *P < 0.05;
**P < 0.01; ****P < 0.0001 for (D) to (G) (Mann-Whitney test).
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Testing additional MDCF prototypes
in gnotobiotic mice
Incorporating tilapia into MDCF prototypes poses
several problems: Its organoleptic properties
are not desirable, and its cost is higher than
Gehrig et al., Science 365, eaau4732 (2019)

commonly consumed plant-based sources of
protein. To identify alternatives to tilapia, we
selected an additional 16 plant-derived complementary food ingredients with varied levels and
quality of protein (25) that are culturally acceptable, affordable, and readily available in
Bangladesh (fig. S4A and table S13, A and B).
Their effects were tested in gnotobiotic mice
colonized with a defined, expanded consortium
of 18 age- and growth-discriminatory bacterial
strains (table S6A). We generated 48 mouse diets
by supplementing a prototypic base diet representative of that consumed by 18-month-old children living in Mirpur (Mirpur-18), with each of
the individual ingredients incorporated at three
different concentrations (fig. S4A and table S13A).
The results revealed that in this defined community context, peanut flour had the greatest effect
on the largest number of targeted weaning-phase
age-discriminatory taxa, followed by chickpea
flour (fig. S4B and table S13C). Soy flour, which
promoted the representation of two of these
taxa, had the second-highest percentage protein after peanut flour (fig. S4A), and its protein
quality was among the highest of the ingredients tested (table S13B). On the basis of these
observations, we chose soy and peanut flours as
replacements for tilapia in subsequent MDCF
formulations.
We reasoned that by transplanting a representative immature intact microbiota into young,
germ-free mice, we could investigate whether gut
health (defined by relative abundances of community members, expression of microbial genes
in mcSEED metabolic pathways, and biomarkers and mediators of gut barrier function) was
improved by supplementing the Mirpur-18 diet
with one or more complementary food ingredients
that target weaning-phase age-discriminatory taxa.
Fifteen fecal samples from 12 different children,
obtained during or after treatment for SAM, were
screened in gnotobiotic mice to identify samples
containing the greatest number of transmissible weaning-phase age-discriminatory taxa and
to assess their response to supplementation of
Mirpur-18 (table S14A). We selected a sample
obtained from a donor (PS.064) who had postSAM MAM; in addition to the successful transmission of targeted taxa, 88.7 ± 1.3% (mean ± SD) of
the recipient animals’ gut communities consisted
of OTUs that were detected at >0.1% relative
abundance in the donor sample (table S14B).
Three groups of mice were colonized with this
microbiota and monotonously fed one of three
diets: unsupplemented Mirpur-18, Mirpur-18 supplemented with peanut flour [Mirpur(P)], or
Mirpur-18 supplemented with four of the lead
ingredients [Mirpur(PCSB), with peanut flour,
chickpea flour, soy flour, and banana] (Fig. 4A
and table S15A). Three control groups were maintained as germ-free; each group was fed one of the
three diets.
We characterized the effects of diet supplementation on cecal and serum levels of metabolites as well as on expression of genes in various
microbial metabolic pathways (tables S15, B, D,
and E, and S16 and supplementary text, results).

12 July 2019

Eighteen mcSEED pathway modules involved
in amino acid metabolism were significantly
up-regulated in the cecal microbiomes of mice
consuming Mirpur(PCSB) or Mirpur(P) compared with those consuming Mirpur-18, with
the most up-regulated being “isoleucine, leucine,
valine biosynthesis” [other age-discriminatory
mcSEED pathway modules that showed significantly lower abundances in the fecal microbiomes
of Bangladeshi children with SAM and whose
expression was increased by Mirpur(PCSB) or
Mirpur(P) in gnotobiotic mice are provided in
Fig. 4B and fig. S1E]. Serum levels of a product of
branched-chain amino acid metabolism, C5:1acylcarnitine, were significantly higher in mice
consuming Mirpur(PCSB) compared with unsupplemented Mirpur-18 (0.148 ± 0.015 versus
0.086 ± 0.0098 mM, respectively; P = 0.014, unpaired t test). Findings from mass spectrometric
analysis of cecal contents, isolation, and comparative genomic analysis of an F. prausnitzii strain
prominently represented in the transplanted
community, and characterization of the in vivo
transcriptional responses of this strain to the
different diets, are described in table S15F and
supplementary text results.
Gut mucosal barrier function
Epithelium and overlying mucus from the proximal, middle, and distal thirds of the small intestine
were recovered with laser capture microdissection (LCM) (Fig. 4D). Listed in table S15C are the
30 most abundant OTUs identified by means of
V4-16S rDNA analysis of LCM mucosal DNA obtained from the different small intestinal segments within a given diet group and between
similarly positioned segments across the different diet treatments. For example, Mirpur(PCSB)
produced a statistically significant increase in
the relative abundance of F. prausnitzii in the
proximal two-thirds of the small intestine, without significantly affecting the proportional representation of a milk-associated age-discriminatory
Bifidobacteria OTU (Fig. 4, C and D).
Gene expression was characterized in the
jejunal mucosa (Fig. 4D, SI-2 segment) recovered
by LCM from mice belonging to all six treatment groups. Significant differences in expression were categorized based on enriched Gene
Ontology (GO) terms for “Molecular Function.”
In colonized mice, Mirpur(P) and Mirpur(PCSB)
significantly up-regulated genes assigned to
“cadherin binding” (GO: 0045296) and “cell adhesion molecule binding” (GO: 0050839) compared with Mirpur-18 (table S17A). The diet effect
was colonization-dependent; there were no significant differences in expression of these genes or
these GO categories in germ-free mice consuming supplemented versus unsupplemented diets
(table S17). (Further discussion is available in the
supplementary text, results, and histochemical
and immunohistochemical analyses of tissue
sections prepared along the length of the small
intestines of these mice are provided in fig. S6).
On the basis of its effects on microbial community organismal composition, gene expression,
and gut barrier function, we deemed Mipur-18
6 of 12
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IGF-1 binding to its receptor tyrosine kinase,
IGF-1R, affects a variety of signal transduction
pathways, including one involving the serine/
threonine kinase Akt/PKB, phosphatidylinositol-3
kinase (PI3K), and the mammalian target of
rapamycin (mTOR). Absorption of several amino
acids from the gut—notably, branched-chain
amino acids and tryptophan—leads to activation
of mTOR (22). Colonized animals fed MDCF had
significantly higher levels of hepatic phosphoSer473Akt, which is consistent with activation of Akt
by IGF-1 signaling through the PI-3K pathway
(Fig. 3E). Levels of phospho–AMPK (5′ adenosine monophosphate-activated protein kinase)
were not significantly affected by diet (Fig. 3E),
suggesting that Akt phosphorylation is not caused
indirectly by altered hepatic energy status. Phosphorylation of hepatic Jak 2 (Tyr1007/1008) and
mTOR (Ser2448), which are involved in IGF-1
production, was significantly increased in colonized mice consuming MDCF (Fig. 3E), whereas
phosphorylation of STAT5, also implicated in
IGF-1 production, was not significantly altered.
Previous studies of adult germ-free mice reported increases in serum IGF-1 after their colonization with gut microbiota from conventionally
raised mice; increased IGF-1 levels were also associated with increased bone formation (23, 24).
Micro-computed tomography (mCT) of mouse
femurs revealed a significant increase in femoral
cortical bone area in MDCF-fed animals; the
effect was both diet- and microbiota-dependent
(Fig. 3F).
We used targeted MS to quantify levels of
amino acids, acyl–coenzyme As (acylCoAs), acylcarnitines, and organic acids in serum, liver,
and gastrocnemius muscle (table S12). Products
of nonoxidative metabolism of glucose and pyruvate (lactate from glycolysis and alanine from
transamination of pyruvate, respectively) were
significantly lower in mice fed MDCF compared
with mice fed MS/KH; this was true for alanine
in serum, skeletal muscle, and liver and for lactate in liver (table S12, A to C and H). Oxidative
metabolism of glucose is associated with nutritionally replete, anabolic conditions. These findings are consistent with the observed elevations
of the anabolic hormone IGF-1 in MDCF-fed compared with MS/KH–fed mice. MDCF-fed mice
had significantly higher circulating levels of
branched-chain amino acids than those of their
MS/KH–fed counterparts (Fig. 3G and table S12,
A to C). Skeletal muscle C5 carnitine and the
closely related metabolite C5-OH/C3 carnitine
were significantly higher in animals consuming
MDCF (Fig. 3G and table S12F). In liver, C3 and C5
acylcarnitines were significantly lower in MDCFtreated mice (Fig. 3G and table S12E), suggesting
that the more nutritionally replete state associated with MDCF may act to limit branchedchain amino acid oxidation in this tissue.
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supplemented with the four lead complementary
foods [Mirpur(PCSB)] superior to that supplemented with just peanut flour [Mirpur(P)].
Characterizing MDCF prototypes
in gnotobiotic piglets
We examined the effects of MDCF prototypes
in a second host species whose physiology and
metabolism are more similar to that of humans.
Gnotobiotic piglets provide an attractive model
for these purposes; piglets manifest rapid growth
rates in the weeks after birth (26), and methods
for conducting experiments with gnotobiotic
piglets have been described (27).
On the basis of the results from the gnotobiotic
mouse studies, we designed two MDCF prototypes. One prototype was formulated to be analogous to Mirpur-18, which contains milk powder;
this prototype was supplemented with peanut
flour, chickpea flour, soy flour, and banana
[MDCF(PCSB)]. The other diet lacked milk powder
and was supplemented with just chickpea flour
and soy flour [MDCF(CS)]. The two MDCFs were
isocaloric, matched in lipid levels and total protein
Gehrig et al., Science 365, eaau4732 (2019)

mcSEED subsystem/pathway module; all P values are FDR-adjusted).
(C) Effects of supplementing Mirpur-18 with one or all four complementary
food ingredients on the relative abundances of a weaning-phase– and a
milk-phase–associated taxon in feces obtained at dpg 21 (one-way ANOVA
followed by Tukey’s multiple comparisons test). (D) Relative abundances
of the two taxa in mucosa harvested by means of LCM from the proximal,
middle, and distal thirds of the small intestine. (Right) Schematic of
locations in the small intestine where LCM was performed. The same
color code for diets is used in (A) to (D). *P < 0.05; **P < 0.01; ****P <
0.0001 (Mann-Whitney test).

content (with equivalent representation of amino
acids), and also met current ready-to-use therapeutic food guidelines for children with respect to
macro- and micronutrient content (table S18A) (28).
Four-day-old germ-free piglets fed a sow milk–
based formula were colonized with a 14-member
consortium of bacterial strains that consisted
of the same nine Bangladeshi age-discriminatory
strains used for the diet oscillation experiments
described in fig. S2, plus five weaning-phase agediscriminatory strains cultured from Malawian
children (table S6B). In an earlier study, several members of this consortium (B. longum,
F. prausnitzii, Clostridium, Ruminococcus gnavus,
and D. formicigenerans) had been classified as
growth-discriminatory by means of a RF-based
analysis of their representation in gnotobiotic
mouse recipients of healthy and undernourished
donor microbiota and the animals’ weight and
lean body mass gain phenotypes (4). After gavage, the two groups of piglets were weaned over
the course of 10 days (supplementary materials,
materials and methods) onto one or the other
irradiated MDCF prototypes, which they con-
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sumed ad libitum for the remainder of the experiment (n = 4 piglets/treatment arm) (Fig.
5A). Animals were euthanized on day 31 after a
6-hour fast.
Piglets fed MDCF(PCSB) exhibited significantly greater weight gain than those receiving
MDCF(CS) (Fig. 5B). Micro-computed tomography of their femurs revealed that they also had
significantly greater cortical bone volume (Fig.
5C). COPRO-seq analysis disclosed that piglets fed MDCF(PCSB) had significantly higher
relative abundances of C. symbiosum, R. gnavus,
D. formicigenerans, R. torques, and Bacteroides
fragilis in their cecum and distal colon compared
with those of piglets consuming MDCF(CS) (Fig.
5D and table S18B); all are weaning-phase agediscriminatory strains, and the former three
were, as noted above, also defined as growthdiscriminatory. Conversely, the relative abundances
of three members of Bifidobacteria (including
two milk-associated age-discriminatory strains,
B. breve and B. longum subsp. infantis) were
significantly higher in the ceca and distal colons of piglets fed MDCF(CS) (table S18B). These
7 of 12
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Fig. 4. Effects of Mirpur-18 diet supplementation on a post-SAM
MAM donor microbiota transplanted into gnotobiotic mice. (A)
Experimental design. dpg, days post gavage of the donor microbiota;
Mirpur(P), Mirpur-18 supplemented with peanut flour; Mirpur(PCSB),
Mirpur-18 supplemented with peanut flour, chickpea flour, soy flour, and
banana. (B) Expression of microbial mcSEED metabolic pathway/modules
in the ceca of gnotobiotic mouse recipients of the post-SAM MAM donor
gut community as a function of diet treatment. *P < 0.05; **P < 0.001;
***P < 0.0001 (statistical comparisons indicate results of gene set
enrichment analysis expression on a per-gene basis across the indicated
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findings led us to conclude that MDCF(PCSB)
promoted a more weaning-phase–like (mature)
community configuration than MDCF(CS). (genome annotations, microbial RNA-seq, and targeted MS analyses of cecal metabolites are
provided in tables S18, C and D, and S19A and
supplementary text, results).
The effects of the two MDCF prototypes on
host biology were defined by means of MSbased serum metabolomic and proteomic analyses (tables S19 and S20). Notable findings
included significant increases in levels of tryptophan, methionine, and C3-acylcarnitine with
MDCF(PCSB) as well as changes produced in the
serum proteome that are shared with children
in the SAM trial (Fig. 5, E and F, and supplementary text, results).
Testing MDCFs in Bangladeshi
children with MAM

the four treatment groups (14 to 17 children per
group) and received 4 weeks of twice-daily
feeding under supervision at the study center,
preceded and followed by 2 weeks of observation and sample collection. Mothers were encouraged to continue their normal breastfeeding
pactices throughout the study (Fig. 6A). There
were no significant differences in the mean daily
amount of each MDCF or RUSF consumed per
child or in the mean incidence of morbidity
across the four treatment groups (table S21, B to
D). All three MDCFs and the RUSF control improved WHZ scores [–1.9 ± 0.5 (mean ± SD) at
the completion of intervention compared with
–2.2 ± 0.4 at the start of intervention; n = 63
children, P = 2.06 × 10−11 for all groups combined, paired t test]. There were no statistically
significant differences between the four interventions in the change in WHZ (P = 0.31, oneway ANOVA). Despite the small group size and
the short length of the study, there were significant differences in treatment effects on another
anthropometric indicator, with MDCF-2 producing a significantly greater increase in mid-upper
arm circumference (MUAC) than MDCF-3 (oneway ANOVA, P = 0.022; with Tukey’s multiple
comparisons test, P = 0.017) (table S21E).
Effects on biological state

Fig. 5. Effects of two different MDCF prototypes in gnotobiotic piglets. (A) Experimental
design. (B) Weight gain in piglets weaned onto isocaloric MDCF prototypes containing either peanut
flour, chickpea flour, soy flour, and banana [MDCF(PCSB)] or chickpea and soy flours [MDCF(CS)].
(C) mCT of femoral bone obtained at euthanasia. (D) Effects of the MDCFs on the relative abundances of community members in cecal and distal colonic contents. (E) Examples of serum proteins
with significantly different post-treatment levels between the two diet groups. (F) Effect of diet
on serum C3 acylcarnitine levels. Mean values ± SD are plotted. *P < 0.05; **P < 0.01; ***P < 0.005,
****P < 0.001 [two-way ANOVA in (B), unpaired t test in (C), (D), and (F)]. The color code
provided in (B) also applies to (C), (D), and (F).
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To contextualize the biological effects of the dietary interventions, we performed quantitative
proteomics (SOMAscan) on plasma collected
from 21 12- to 24-month-old Mirpur children
with healthy growth phenotypes (mean age, 19.2 ±
5.1 months; WHZ, 0.08 ± 0.58; HAZ, –0.41 ± 0.56,
WAZ, –0.12 ± 0.60) and 30 children with SAM
before treatment (Fig. 1A, B1 sample; WHZ < –3;
mean age 15.2 ± 5.1 months) [metadata associated with the healthy, SAM, and MAM (MDCF
trial) cohorts are provided in table S22]. We rankordered all detected proteins according to fold
differences in their abundances in plasma collected
from healthy children compared with children
with untreated SAM. The top 50 most differentially
abundant proteins (P < 10−7; R package “limma”)
that were significantly higher in healthy children
were designated “healthy growth-discriminatory,”
whereas the top 50 differentially abundant proteins that were significantly higher in children
with SAM were designated “SAM-discriminatory”
(table S23A). We next compared the mean difference for each protein in the pre- versus postintervention plasma samples for all children in
each MDCF/RUSF treatment group. Proteins were
then ranked according to the fold differences
of the pre- versus post-treatment levels in each
of the four groups (table S23B), and these treatment effects were mapped onto the 50 most
healthy growth-discriminatory and 50 most SAMdiscriminatory proteins. Strikingly, MDCF-2 elicited
a biological response characterized by a marked
shift in the plasma proteome toward that of healthy
children and away from that of children with SAM;
MDCF-2 increased the abundance of proteins that
are higher in plasma from healthy children and
reduced the levels of proteins elevated in SAM
plasma samples (Fig. 6B).
8 of 12
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To assess the degree to which results obtained
from the gnotobiotic mouse and piglet models
translate to humans, we performed a pilot randomized, double-blind controlled feeding study
of the effects of three MDCF formulations. The

formulations (MDCF-1, -2, and -3) were designed
to be similar in protein energy ratio and fat energy ratio and provide 250 kcal/day (divided over
two servings). MDCF-2 contained all four lead
ingredients (chickpea flour, soy flour, peanut
flour, and banana) at higher concentrations than
in MDCF-1. MDCF-3 contained two lead ingredients (chickpea flour and soy flour). A rice- and
lentil-based ready-to-use supplementary food
(RUSF), included as a control arm, lacked all
four ingredients but was otherwise similar in
energy density, protein energy ratio, fat energy
ratio, and macro- and micronutrient content to
those of the MDCFs (Fig. 6A). Milk powder was
included in MDCF-1 and RUSF. All formulations
were supplemented with a micronutrient mixture
designed to provide 70% of the recommended
daily allowances for 12- to 18-month-old children.
The formulations were produced locally and
tested for organoleptic acceptability before initiating the trial (table S21A).
Children from Mirpur with MAM and no prior
history of SAM were enrolled (mean age at enrollment, 15.2 ± 2.1 months, mean WHZ –2.3 ±
0.3). Participants were randomized into one of
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Aggregating proteomic datasets from the combined cohort of 113 children with SAM, MAM,
and healthy growth phenotypes for whom plasma samples were available, we identified a total
of 27 plasma proteins that were significantly
positively correlated with HAZ and 57 plasma
proteins that were significantly negatively correlated with HAZ [absolute value of Pearson
correlation > 0.25, false discovery rate (FDR)–
corrected P value < 0.05]. Among the treatments,
MDCF-2 was distinctive in its ability to increase
the abundances of a broad range of proteins positively correlated with HAZ, including the major
Gehrig et al., Science 365, eaau4732 (2019)

IGF-1 binding protein IGFBP-3, growth hormone
receptor (GHR), and leptin (LEP) (Fig. 6C). Growth
differentiation factor 15 (GDF15) was reduced
after 4 weeks of dietary supplementation with
MDCF-2 (Fig. 6C). This transforming growth
factor–b superfamily member, which was negatively correlated with HAZ, has been implicated
in the anorexia and muscle wasting associated
with cancer and with chronic heart failure in
children; it was elevated in children with SAM
and positively correlated with their lipolytic
biomarkers NEFA and ketones (supplementary
text, results). Peptide YY, an enteroendocrine cell

12 July 2019

Effects on the microbiota
Our analysis of fecal microbiota samples revealed no significant change in the representation of enteropathogens within and across the
four treatment groups (fig. S7A and table S21F).
MDCF-2–induced changes in biological state
9 of 12
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Fig. 6. Comparing the effects of MDCF formulations on the health status of Bangladeshi
children with MAM. (A) Study design and composition of diets. Total carbohydrate includes all
components except added sugar. (B) Quantitative proteomic analysis of the average fold-change,
per treatment group, in the abundances of the 50 plasma proteins most discriminatory for
healthy growth and the 50 plasma proteins most discriminatory for SAM (protein abundance is
column-normalized across treatment groups). (C) Average fold-change in abundances of plasma
proteins that significantly positively or negatively correlate with HAZ [absolute value of Pearson
correlation > 0.25, FDR-corrected P value < 0.05; abundance is column-normalized as in (B)].

product elevated in SAM plasma that reduces
appetite and negatively correlated with HAZ,
was also decreased by MDCF-2.
We identified GO terms that were enriched
among the group of treatment-responsive proteins and ranked them according to the P value
of their enrichment (table S23C). Proteins belonging to GO terms significantly higher in healthy
compared with SAM plasma samples were deemed
“healthy growth-discriminatory,” whereas those
that were significantly higher in SAM were deemed
“SAM-discriminatory” (fold-difference >30%; FDRadjusted P value <0.05). This analysis revealed
multiple healthy growth-discriminatory proteins
associated with GO processes “osteoblast differentiation” and “ossification” that were increased
by supplementation with MDCF-2 (Fig. 7A and
table S23C). Examples include key markers or
mediators of osteoblast differentiation [osteopontin (SPP1), bone sialoprotein 2 (IBSP), and
bone morphogenetic protein 7 (BMP7)] as well as
matrix metalloproteases (MMP-2 and MMP-13)
involved in terminal differentiation of osteoblasts
into osteocytes and bone mineralization.
A number of plasma proteins categorized under the GO process “CNS development,” including those involved in axon guidance and neuronal
differentiation, were also affected by MDCF-2 supplementation. Levels of the SAM-discriminatory
semaphorin SEMA3A, a potent inhibitor of axonal
growth, decreased with this treatment, whereas healthy growth-discriminatory semaphorins
(SEMA5A, SEMA6A, and SEMA6B) increased
(Fig. 7B). Other healthy growth-discriminatory
proteins whose abundances increased with
MDCF-2 included receptors for neurotrophin
(NTRK2 and NTRK3) plus various axonal guidance
proteins [netrin (UNC5D), ephrin A5 (EFNA5),
roundabout homolog 2 (ROBO2), and SLIT and
NTRK-like protein 5 (SLITRK5)] (Fig. 7B). Expression of a number of neurotrophic proteins
belonging to these families has been reported
to be influenced by nutrient availability in primates (29).
Compared with healthy children, the plasma
proteome of children with SAM was characterized by elevated levels of acute phase proteins
[such as C-reactive protein (CRP) or interleukin6 (IL-6)] and inflammatory mediators, including
several agonists and components of the nuclear
factor–kB (NF-kB) signaling pathway (Fig. 7C).
These components include the pro-inflammatory
cytokines IL-1b, tumor necrosis factor–a (TNF-a),
and CD40L, plus ubiquitin-conjugating enzyme
E2 N (UBE2N), which is involved in induction
of NF-kB– and mitogen-activated protein kinase
(MAPK)–responsive inflammatory genes (30).
MDCF-2 supplementation was associated with
reductions in the levels of all of these SAMassociated proteins (Fig. 7C).
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tions. Interpretation of this finding was confounded by unexpectedly high baseline microbiota
maturity scores in this group of children with
MAM [MAZ, –0.01 ± 1.12 (mean ± SD)] (table
S22) compared with a small, previously characterized Mirpur cohort with untreated MAM
(2). Hence, we developed an additional measure
of microbiota repair (31). This involved a statistical analysis of covariance among bacterial taxa
in the fecal microbiota of anthropometrically
healthy members of a Mirpur birth cohort who
had been sampled monthly over a 5-year period.
Using approaches developed in the fields of
econophysics and protein evolution to characterize the underlying organization of interacting
systems with seemingly intractable complexity,
such as financial markets, we found that the gut
community in healthy children could be decomposed into a sparse unit of 15 covarying bacterial
taxa termed an “ecogroup” (31). These ecogroup
taxa include a number of age-discriminatory
strains in the Bangladeshi RF-derived model
(such as B. longum, F. prausnitzii, and Prevotella
copri). We used the ecogroup to show that in
addition to its effects on host biological state,
MDCF-2 was also the most effective of the four
treatments in reconfiguring the gut bacterial

community to a mature state similar to that
characteristic of healthy Bangladeshi children.
Conclusions
We have integrated preclinical gnotobiotic animal models with human studies to understand
the contributions of perturbed gut microbiota
development to childhood undernutrition and
to identify new microbiota-directed therapeutic approaches. We identified a set of proteins
that distinguish the plasma proteomes of healthy
children from those with SAM. Using these data,
we have developed a supplemental food prototype, MDCF-2, that shifted the plasma proteome
of children with MAM toward that of healthy
individuals, including proteins involved in linear
growth, bone development, neurodevelopment,
and immune function. MDCF-2 is a tool for investigating, in larger studies across different
populations with varying degrees of undernutrition, how repair of gut microbiota immaturity
affects various facets of child growth.
Overview of methods
Human studies
Children aged 6 to 59 months with SAM (n =
343 participants) were enrolled in a study entitled “Development and field testing of readyto-use therapeutic foods (RUTF) made of local
ingredients in Bangladesh for the treatment of
children with severe acute malnutrition.” The
study was approved by the Ethical Review Committee at icddr,b (ClinicalTrials.gov identifier
NCT01889329). Written informed consent was
obtained from their parent or guardian. A subset of 54 children were included in a substudy
that involved regular fecal sampling and three
blood draws for up to 1 year after discharge.
Children aged 12 to 18 months with MAM who
were no longer exclusively breastfed (n = 63
participants) were enrolled in a double-blind,
randomized, four-group, parallel assignment
interventional trial study (ClinicalTrials.gov identifier NCT03084731) approved by the Ethical
Review Committee at icddr,b. Fecal and plasma
samples were collected as described in the supplementary materials, materials and methods,
and stored at –80°C. Samples were shipped to
Washington University with associated clinical
metadata and maintained in a dedicated biospecimen repository with approval from the
Washington University Human Research Protection Office.
Analysis of plasma samples

Fig. 7. The effects of different MDCF formulations on biomarkers and mediators of bone and
CNS development, plus NF-kB signaling. (A to C) Average fold-change (normalized across treatment groups) in the abundances of plasma proteins belonging to GO categories related to (A) bone,
(B) CNS development, and (C) agonists and components of the NF-ĸB signaling pathway. Proteins in
the GO category that were significantly higher in the plasma of healthy compared with SAM children
(fold-difference >30%; FDR-adjusted P value < 0.05) are labeled “healthy growth-discriminatory,” whereas
those higher in SAM compared with healthy children (fold-difference >30%; FDR-adjusted P value
< 0.05) are labeled “SAM-discriminatory.” Levels of multiple “healthy growth-discriminatory” proteins
associated with (A) GO processes “osteoblast differentiation” and “ossification”, and (B) the GO process
“CNS development” are enhanced by MDCF-2 treatment while (C) NF-kB signaling is suppressed.
Gehrig et al., Science 365, eaau4732 (2019)
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Methods for targeted MS-based metabolomics
are described in the supplementary materials.
The SOMAscan 1.3K Proteomic Assay plasma/
serum kit (SomaLogic, Boulder, Colorado,) was
used to measure 1305 proteins. The R package
“limma” (Bioconductor) was used to analyze
differential protein abundances (32). Spearman
correlation analyses were performed between
measured proteins and anthropometric scores,
plasma metabolites, and the abundances of bacterial taxa in fecal samples. Plasma proteins in
children with healthy growth phenotypes or SAM
10 of 12
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were accompanied by increases in the relative
abundances of several weaning-phase taxa, including OTUs assigned to F. prausnitzii (OTU
851865) and a Clostridiales sp. (OTU 338992)
that are closely related to taxa ranked first and
second in feature importance in the sparse
Bangladeshi RF-derived model of gut microbiota
maturation (fig. S7, B and C). MDCF-2 supplementation was associated with a significant
decrease in B. longum (OTU 559527) (fig. S7B),
which is ranked third in feature importance in
the RF-derived model and discriminatory for a
young, milk-oriented microbiota. None of the
other members of the 30 OTU model showed
significant changes. By contrast, MDCF-1 did
not produce significant increases in any of the
taxa in the model. The other two formulations
were each associated with a significant change
in just one member [an increase in the relative
abundance of an early age-discriminatory OTU
(Streptococcus; ranked 30th) with MDCF-3 supplementation, and a decrease in another OTU
(Enterococcus faecalis; ranked 29th) with RUSF
supplementation] (table S4B).
MAZ scores were not significantly different
between groups at enrollment, nor were they
significantly improved by any of the formula-

Corrected 11 July 2019. See full text.
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Characterizing human fecal microbial
communities
Methods for V4-16S rRNA gene sequencing and
data analysis, calculation of MAZ scores and
functional microbiome maturity, and quantification of enteropathogen burden by means of
multiplex quantitative polymerase chain reaction (qPCR) are described in the supplementary materials.
Animal studies
Gnotobiotic mice
All mouse experiments were performed by using
protocols approved by the Washington University Animal Studies Committee. Mice were
housed in plastic flexible film gnotobiotic isolators under a 12-hour light cycle. Male germ-free
C57BL/6 mice were initially weaned onto an autoclaved, low-fat, high-plant polysaccharide chow
that was administered ad libitum (diet 2018S,
Envigo). Animals were maintained on this diet
until 3 days before the beginning of experiments
involving tests of the effects of complementary
food ingredients. Defined consortia of sequenced
bacterial strains cultured from Bangladeshi children, or intact uncultured microbiota from donors with post-SAM MAM, were introduced by
means of gavage into recipient mice at 5 weeks of
age. Methods for identifying and characterizing
Gehrig et al., Science 365, eaau4732 (2019)

the effects MDCF prototypes—including (i) design
and preparation of diets; (ii) culturing of agediscriminatory and SAM-associated bacterial
strains; (iii) shotgun sequencing of DNA isolated
from serially collected fecal samples; (iv) microbial RNA-seq of cecal contents; (v) targeted MS of
cecal contents, liver, gastrocnemius muscle, and
serum samples for measurement of amino acids,
acylcarnitines, organic acids, and acylCoAs; (vi)
Western blot analysis of IGF-1 pathway components in liver; (vii) mCT of bone; and (viii)
characterizing the effects of a transplanted fecal
microbiome from a donor with post-SAM MAM
in recipient gnotobiotic mice as a function of diet
treatment by histochemical and immunohistochemical analysis of their intestinal segments,
LCM of their small intestinal epithelium, and
RNA-seq analysis of gene expression in LCM
mucosa—are all described in the supplementary
materials.
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Gnotobiotic piglets
Experiments were performed under the supervision of a veterinarian by using protocols approved
by the Washington University Animal Studies
Committee and that followed American Veterinary Medical Association guidelines for euthanasia. The protocol for generating germ-free
piglets; preparing diets, feeding, colonization,
and husbandry of piglets; measurement of weight
gain; mCT of femurs; and liquid chromatography–
MS (LC-MS)/MS–based serum proteomics are all
described in the supplementary materials.
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(before treatment) were rank-ordered according
to the fold-difference in their levels between
these two groups. The top 50 most differentially
abundant proteins in healthy compared with SAM
were designated as healthy growth-discriminatory
proteins, and the top 50 most differentially
abundant in SAM compared with healthy were
designated as SAM-discriminatory proteins.
The average fold-change for these healthy growthand SAM-discriminatory proteins was then calculated for each treatment arm in the MDCF trial
(before versus after MDCF/RUSF treatment) and
normalized to the mean fold-change across all
four arms. Limma was used to calculate statistical significance. All 1305 proteins were mapped
to all GO “Biological Processes” in the GO database (www.geneontology.org). SetRank, a gene
set enrichment analysis (GSEA) algorithm (33),
was used to identify GO Biological Processes
that were significantly enriched for proteins
that exhibited changes in abundance from before to after treatment with MDCF/RUSF. Enrichment was calculated by using the setRankAnalysis
function in the SetRank R library (parameters
were use.ranks = TRUE; setPCutoff = 0.01; and
fdrCutoff = 0.05). The average fold-change for
each protein in the statistically significant Biological Process category was calculated for each
treatment arm and normalized to the mean foldchange across all four arms. We defined proteins
within the GO Biological Process as “healthy
growth-discriminatory” if they were at least 30%
more abundant in healthy individuals compared
with those with SAM and “SAM-discriminatory”
if they were at least 30% more abundant in children with SAM compared with those who were
classified as healthy.
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